ORX:STO
Orexo AB
SEKÂ 1.37
arrow_downward
-1.58%(-0.022) 1D
Nov 6, 5:29:49 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 1.47
High
SEKÂ 1.47
Low
SEKÂ 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 1.30
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 1.47
High
SEKÂ 1.47
Low
SEKÂ 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 1.30
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
RealMoney Pro
·
54 minutes ago
Tech Bounces, but the S&P 500 Still Has Its Worst Week Since April 2025
inkl
·
12 minutes ago
Nasdaq, S&P 500, Russell 2000 jump, Dow Jones down at US Stock Market, check top performing Wall Street stocks
www.tokenpost.com
·
28 minutes ago
Nasdaq Composite Falls More Than 10% From Oct. 6 Closing High
www.tmgm.com
·
3 hours ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com